Chargement en cours...
New strategies for cancer immunotherapy: targeting regulatory T cells
The immunosuppressive action of regulatory T (T(reg)) cells is one mechanism attributed to the limited success of cancer immunotherapies with checkpoint blockers. Two recent studies report distinct transcriptional profiles of tumor-infiltrating T(reg) cells and expression of specific molecules, sugg...
Enregistré dans:
| Publié dans: | Genome Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5273791/ https://ncbi.nlm.nih.gov/pubmed/28129791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-017-0402-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|